Testing effectiveness (Phase 2)Temporarily pausedNCT04111172
What this trial is testing
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal AdenocarcinomaGastric Adenocarcinoma+35 more
Thomas Jefferson University 48